Literature DB >> 24143907

Impact of islet size on pancreatic islet transplantation and potential interventions to improve outcome.

Daria Zorzi1, Tammy Phan, Marco Sequi, Yong Lin, Daniel H Freeman, Luca Cicalese, Cristiana Rastellini.   

Abstract

Better results have been recently reported in clinical pancreatic islet transplantation (ITX) due mostly to improved isolation techniques and immunosuppression; however, some limitations still exist. It is known that following transplantation, 30% to 60% of the islets are lost. In our study, we have investigated 1) the role of size as a factor affecting islet engraftment and 2) potential procedural manipulations to increase the number of smaller functional islets that can be transplanted. C57/BL10 mice were used as donors and recipients in a syngeneic islet transplant model. Isolated islets were divided by size (large, >300 μm; medium 150-300 μm; small, <150 μm). Each size was transplanted in chemically induced diabetic mice as full (600 IEQ), suboptimal (400 IEQ), and marginal mass (200 IEQ). Control animals received all size islets. Engraftment was defined as reversal of diabetes by day 7 posttransplantation. When the superiority of smaller islets was observed, strategies of overdigestion and fragmentation were adopted during islet isolation in the attempt to reduce islet size and improve engraftment. Smaller islets were significantly superior in engraftment compared to medium, large, and control (all sizes) groups. This was more evident when marginal mass data were compared. In all masses, success decreased as islet size increased. Once islets were engrafted, functionality was not affected by size. When larger islets were fragmented, a significant decrease in islet functionality was observed. On the contrary, if pancreata were slightly overdigested, although not as successful as small naive islets, an increase in engraftment was observed when compared to the control group. In conclusion, smaller islets are superior in engraftment following islet transplantation. Fragmentation has a deleterious effect on islet engraftment. Islet isolations can be performed by reducing islet size with slight overdigestion, and it can be safely adopted to improve clinical outcome.

Entities:  

Mesh:

Year:  2013        PMID: 24143907      PMCID: PMC4841262          DOI: 10.3727/096368913X673469

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  55 in total

1.  Islet transplantation: a brave new world.

Authors:  Camillo Ricordi
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

Review 2.  Prediction of clinical outcome in islet allotransplantation.

Authors:  Federico Bertuzzi; Camillo Ricordi
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

3.  Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.

Authors:  M D Bellin; R Kandaswamy; J Parkey; H-J Zhang; B Liu; S H Ihm; J D Ansite; J Witson; P Bansal-Pakala; A N Balamurugan; K K Papas; K Papas; D E R Sutherland; A Moran; B J Hering
Journal:  Am J Transplant       Date:  2008-09-19       Impact factor: 8.086

4.  Small rat islets are superior to large islets in in vitro function and in transplantation outcomes.

Authors:  R R MacGregor; S J Williams; P Y Tong; K Kover; W V Moore; L Stehno-Bittel
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-22       Impact factor: 4.310

5.  Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study.

Authors:  Paola Maffi; Marina Scavini; Carlo Socci; Lorenzo Piemonti; Rossana Caldara; Chiara Gremizzi; Raffaella Melzi; Rita Nano; Elena Orsenigo; Massimo Venturini; Carlo Staudacher; Alessandro Del Maschio; Antonio Secchi
Journal:  Rev Diabet Stud       Date:  2011-05-10

6.  Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.

Authors:  Sophie Borot; Nadja Niclauss; Anne Wojtusciszyn; Coralie Brault; Sandrine Demuylder-Mischler; Yannick Müller; Laurianne Giovannoni; Géraldine Parnaud; Raphael Meier; Lionel Badet; François Bayle; Luc Frimat; Laurence Kessler; Emmanuel Morelon; Alfred Penfornis; Charles Thivolet; Christian Toso; Philippe Morel; Domenico Bosco; Cyrille Colin; Pierre-Yves Benhamou; Thierry Berney
Journal:  Transplantation       Date:  2011-11-15       Impact factor: 4.939

7.  Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion.

Authors:  D W Hopcroft; D R Mason; R S Scott
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

8.  Glucose-induced insulin release depends on functional cooperation between islet cells.

Authors:  D Pipeleers; P I in't Veld; E Maes; M Van De Winkel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Revascularization and remodelling of pancreatic islets grafted under the kidney capsule.

Authors:  Sergio Morini; Melissa L Brown; Luca Cicalese; George Elias; Simone Carotti; Eugenio Gaudio; Cristiana Rastellini
Journal:  J Anat       Date:  2007-03-29       Impact factor: 2.610

10.  Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts.

Authors:  D B Kaufman; J L Platt; F L Rabe; D L Dunn; F H Bach; D E Sutherland
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  7 in total

1.  iPreP is a three-dimensional nanofibrillar cellulose hydrogel platform for long-term ex vivo preservation of human islets.

Authors:  Yi-Ju Chen; Taiji Yamazoe; Karla F Leavens; Fabian L Cardenas-Diaz; Andrei Georgescu; Dongeun Huh; Paul Gadue; Ben Z Stanger
Journal:  JCI Insight       Date:  2019-11-01

Review 2.  The Flaws and Future of Islet Volume Measurements.

Authors:  Han-Hung Huang; Stephen Harrington; Lisa Stehno-Bittel
Journal:  Cell Transplant       Date:  2018-06-28       Impact factor: 4.064

Review 3.  Review of Advanced Hydrogel-Based Cell Encapsulation Systems for Insulin Delivery in Type 1 Diabetes Mellitus.

Authors:  Albert Espona-Noguera; Jesús Ciriza; Alberto Cañibano-Hernández; Gorka Orive; Rosa María María Hernández; Laura Saenz Del Burgo; Jose Luis Pedraz
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

4.  Spheroid Fabrication Using Concave Microwells Enhances the Differentiation Efficacy and Function of Insulin-Producing Cells via Cytoskeletal Changes.

Authors:  Yu Na Lee; Hye Jin Yi; Hanse Goh; Ji Yoon Park; Sarah Ferber; In Kyong Shim; Song Cheol Kim
Journal:  Cells       Date:  2020-11-27       Impact factor: 6.600

5.  Inhibition of Dectin-1 on Dendritic Cells Prevents Maturation and Prolongs Murine Islet Allograft Survival.

Authors:  Ao Ren; Zhongqiu Li; Xuzhi Zhang; Ronghai Deng; Yi Ma
Journal:  J Inflamm Res       Date:  2021-01-12

6.  Engineering Vascularized Islet Macroencapsulation Devices: An in vitro Platform to Study Oxygen Transport in Perfused Immobilized Pancreatic Beta Cell Cultures.

Authors:  Fernandez S A; Champion K S; Danielczak L; Gasparrini M; Paraskevas S; Leask R L; Hoesli C A
Journal:  Front Bioeng Biotechnol       Date:  2022-04-19

7.  Comparison of the Effects of Liraglutide on Islet Graft Survival Between Local and Systemic Delivery.

Authors:  Song Mi Lee; Donghee Kim; Kyung Min Kwak; Phyu Phyu Khin; Oh Kyung Lim; Kwang-Won Kim; Byung-Joon Kim; Hee-Sook Jun
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.